The Peptide Encyclopedia
Independent, sourced profiles of 30+ peptides. Each entry flags regulatory status honestly — approved medicine, research chemical, or somewhere in between — and links to primary research.
5 peptides
A small-molecule NNMT inhibitor (not a peptide) studied in preclinical metabolic research; included for completeness as it is commonly grouped with research peptides.
A modified fragment of human growth hormone (176-191) investigated for fat-metabolism effects; failed to show significant weight-loss efficacy in trials.
An investigational triple GIP/GLP-1/glucagon receptor agonist in late-stage clinical trials for obesity; not yet approved.
A GLP-1 receptor agonist approved for type 2 diabetes (Ozempic/Rybelsus) and chronic weight management (Wegovy). One of the most rigorously trialed metabolic drugs.
A dual GIP/GLP-1 receptor agonist approved for type 2 diabetes (Mounjaro) and weight management (Zepbound), with large phase-3 trial programs.